Cargando…
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial
BACKGROUND: Previous trials of the RTS, S malaria candidate vaccine have shown that this vaccine is safe, tolerated and immunogenic. The development plan for this vaccine aims at administering it in the first year of life through the Expanded Program on Immunization (EPI). The objective was to evalu...
Autores principales: | Macete, Eusebio V, Sacarlal, Jahit, Aponte, John J, Leach, Amanda, Navia, Margarita M, Milman, Jessica, Guinovart, Caterina, Mandomando, Inacio, López-Púa, Yolanda, Lievens, Marc, Owusu-Ofori, Alex, Dubois, Marie-Claude, Cahill, Conor P, Koutsoukos, Marguerite, Sillman, Marla, Thompson, Ricardo, Dubovsky, Filip, Ballou, W Ripley, Cohen, Joe, Alonso, Pedro L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847838/ https://www.ncbi.nlm.nih.gov/pubmed/17386091 http://dx.doi.org/10.1186/1745-6215-8-11 |
Ejemplares similares
-
Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
por: Guinovart, Caterina, et al.
Publicado: (2009) -
Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02(D) Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial
por: Aide, Pedro, et al.
Publicado: (2010) -
Impact of the RTS,S Malaria Vaccine Candidate on Naturally Acquired Antibody Responses to Multiple Asexual Blood Stage Antigens
por: Campo, Joseph J., et al.
Publicado: (2011) -
RTS,S/AS02A Malaria Vaccine Does Not Induce Parasite CSP T Cell Epitope Selection and Reduces Multiplicity of Infection
por: Enosse, Sonia, et al.
Publicado: (2006) -
Malaria in rural Mozambique. Part II: children admitted to hospital
por: Bassat, Quique, et al.
Publicado: (2008)